MiMedx Group Inc reports results for the quarter ended in December - Earnings Summary

MiMedx

28/02/2023 22:07

* MiMedx Group Inc  MDXG.OQ  reported a quarterly adjusted
loss
of 2 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 4 cents per share.
    * Revenue rose 10.3% to $74.38 million from a year ago;
analysts
expected $74.53 million. 
    * MiMedx Group Inc's reported EPS for the quarter was a loss
of 2
cents​.
    * The mean earnings estimate of analysts had risen by
about 8.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * MiMedx Group Inc shares had risen by 69.8% this quarter.
    * The company reported a quarterly loss of $2.11 million.
    * Wall Street's median 12-month price target for MiMedx
Group Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 10:06 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.04          -0.02          Beat
 Sep. 30 2022      -0.08          -0.09          Missed
 Jun. 30 2022      -0.06          -0.11          Missed
 Mar. 31 2022      -0.10          -0.11          Missed